Credit Suisse’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $29.8M | Sell |
|
|||||
|
2023
Q4 | $22.9M | Sell |
|
|||||
|
2023
Q3 | $12.9M | Buy |
|
|||||
|
2023
Q2 | $19.7M | Buy |
|
|||||
|
2023
Q1 | $16.5M | Buy |
|
|||||
|
2022
Q4 | $17M | Buy |
|
|||||
|
2022
Q3 | $25M | Sell |
|
|||||
|
2022
Q2 | $29.1M | Buy |
|
|||||
|
2022
Q1 | $41.6M | Buy |
|
|||||
|
2021
Q4 | $46.5M | Buy |
|
|||||
|
2021
Q3 | $59.6M | Buy |
|
|||||
|
2021
Q2 | $62.8M | Buy |
|
|||||
|
2021
Q1 | $75.8M | Buy |
|
|||||
|
2020
Q4 | $1.21M | Sell |
|
|||||
|
2020
Q3 | $1.83M | Sell |
|
|||||
|
2020
Q2 | $2.15M | Buy |
|
|||||
|
2020
Q1 | $228K | Sell |
|
|||||
|
2019
Q4 | $39.5M | Sell |
|
|||||
|
2019
Q3 | $27.8M | Sell |
|
|||||
|
2019
Q2 | $38.5M | Sell |
|
|||||
|
2019
Q1 | $18M | Buy |
|
|||||
|
2018
Q4 | $16.7M | Buy |
|
|||||
|
2018
Q3 | $17.6M | Buy |
|
|||||
|
2018
Q2 | $13.2M | Sell |
|
|||||
|
2018
Q1 | $24.5M | Buy |
|
|||||
|
2017
Q4 | $8.76M | Buy |
|
|||||
|
2017
Q3 | $571K | Buy |
|
|||||
|
2017
Q2 | $196K | Sell |
|
|||||
|
2017
Q1 | $265K | Buy |
|
|||||
|
2016
Q4 | $238K | Sell |
|
|||||
|
2016
Q3 | $366K | Sell |
|
|||||
|
2016
Q2 | $381K | Buy |
|
|||||
|
2016
Q1 | $215K | Sell |
|
|||||
|
2015
Q4 | $335K | Buy |
|
|||||
|
2015
Q3 | $129K | Sell |
|
|||||
|
2015
Q2 | $221K | Sell |
|
|||||
|
2015
Q1 | $641K | Buy |
|